After Gland, Chinese pharma giant Fosun eyes API maker Symbiotec Industry-The Economic Times — October 1, 2017 comments off ??Symbiotec has been an acquisition target for other drug makers and PE players after the Indore-based company was put up for sale.
??Symbiotec has been an acquisition target for other drug makers and PE players after the Indore-based company was put up for sale.